Skip to main content
. 2022 Jul 22;16:880105. doi: 10.3389/fnins.2022.880105

TABLE 1.

The causality of blood lead level and Alzheimer’s disease (AD) risk by two-sample Mendelian randomization (MR) analysis using the data of AD consortium (Kunkle et al., 2019).

SNP Position Effect allele GWAS of blood lead level
GWAS of AD
Model MR analysis
Heterogeneity test
Horizontal pleiotropy
Beta P-value Beta P-value Beta P-value Cochran’s Q P-value Intercept P-value
rs76153987 chr3:9214817 T −0.195 4 × 10–6 −0.073 0.0266
IVW 0.245 0.0103 2.161 0.34
rs116864947 chr7:11705786 T −0.431 3 × 10–7 −0.123 0.0376 −0.029 0.44
WME 0.262 0.0367 0.684 0.41
rs6462018 chr7:27519118 G −0.084 4 × 10–6 −0.002 0.8994